Sargassum hemiphyllum inhibits atopic allergic reaction via the regulation of inflammatory mediators

Journal of Pharmacological Sciences

Volumn 97, Issue 2, 2005, Pages 219-226

  Na, Ho Jeong ^a,b   Moon, Phil Dong ^b   Ko, Seong Gum ^b   Lee, Hee Jung ^c   Jung, Hyun Ah ^c   Hong, Seung Heon ^b   Seo, Youngwan ^c   Oh, Jay Min ^b   Lee, Bong Ho ^d   Choi, Byoung Wook ^d   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Korea Maritime University   (South Korea)

^d Hanbat National University   (South Korea)

Author keywords

Atopic dermatitis; Cytokine; Histamine; Mast cell; Sargassum hemiphyllum

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CALCIMYCIN; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; METHANOL; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; SARGASSUM HEMIPHYLLUM EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL CELL; ARTICLE; ATOPIC DERMATITIS; ATOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; EMBRYO; HISTAMINE RELEASE; HUMAN; HUMAN CELL; KOREA; MAST CELL; MOUSE; NONHUMAN; PERITONEUM MAST CELL; RAT; SARGASSUM HEMIPHYLLUM; TRADITIONAL MEDICINE;

EID: 20144382746     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FP0040326     Document Type: Article

References (59)

1. Wong KH, Cheung PC. Effect of fiber-rich brown seaweeds on protein bioavailability of casein in growing rats. Int J Food Sci Nutr. 2003;54:269-279.
2. Schiewer S, Wong MH. Ionic strength effects in biosorption of metals by marine algae. Chemosphere. 2000;41:271-282.
3. Hopkin JM. Mechanisms of enhanced prevalence of asthma and atopy in developed countries. Allergy. 1998;14:75-79.
4. Taylor ML, Metcalfe DD. Mast cells in allergy and host defense. Allergy Asthma Proc. 2001;22:115-119.
5. Kim HM. Antiallergy drugs from Oriental medicines. Int J Orient Med. 2000;1:1-7.
6. Allansmith MR, Baird RS, Ross RN, Barney NP, Bloch KJ. Ocular anaphylaxis induced in the rat by topical application of compound 48/80. Dose response and time course study. Acta Ophthalmol. 1989;192:145-153.
7. Shin BK, Lee EH, Kim HM. Suppression of L-histidine decarboxylase mRNA expression by methyleugenol. Biochem Biophys Res Commun. 1997;232:188-191.
8. Kim HM, Cho SH. Lavender Oil inhibits immediate-type allergic reaction in mice and rats. J Pharm Pharmacol. 1999;51: 221-226.
9. Kim HM, Yi JM, Lim KS. Magnoliae flos inhibits mast cell-dependent immediate-type allergic reactions. Pharmacol Res. 1999;39:107-111.
10. Holgate ST, Church MK. Allergy. New York: Gower Medical Publishing; 1993. p. 21.3-21.4.
11. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol. 1994;102:128-137.
12. Na HJ, Jeong HJ, Bae H, Kim YB, Park ST, Yun YG, et al. Tongkyutang inhibits mast cell dependent allergic reactions and inflammatory cytokines secretion. Clin Chim Acta. 2002;319: 35-41.
13. Galli SJ. New concepts about the mast cell. N Engl J Med. 1993;328:257-265.
14. Ackermann L, Pelkonen J, Harvima IT. Staphylococcal enterotoxin B inhibits the production of interleukin-4 in a human mast-cell line HMC-1. Immunology. 1998;94:247-252.
15. Swieter M, Midura RJ, Nishikata H, Oliver C, Berenstein EH, Mergenhagen SE, et al. Mouse 3T3 fibroblasts induces rat basophilic leukemia (RBL-2H3) cells to acquire responsiveness to compound 48/80. J Immunol. 1993;150:617-624.
16. Barata LT, Ying S, Meng Q, Barkans J, Rajakulasingam K, Durham SR, et al. IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Allergy Clin Immunol. 1998;101:222-230.
17. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature. 1990; 346:274-276.
18. Trefzer U, Hofmann M, Sterry W, Asadullah K. Cytokine and anti-cytokine therapy in dermatology. Expert Opin Biol Ther. 2003;3:733-743.
19. Lin J, Opoku AR, Geheeb-Keller M, Hutchings AD, Terblanche SE, Jager AK, et al. Preliminary screening of some traditional zulu medicinal plants for anti-inflammatory and anti-microbial activities. J Ethnopharmacol. 1999;68:267-274.
20. Hong SH, Jeong HJ, Kim HM. Inhibitory effects of Xanthii fructus extract on mast cell-mediated allergic reaction in murine model. J Ethnopharmacol. 2003;88:229-234.
21. Yurt RW, Leid RW, Austen KF. Native heparin from rat peritoneal mast cells. J Biol Chem. 1977;252:518-521.
22. Shore PA, Burkhalter A, Cohn VH. A method for fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 1959;127: 182-186.
23. Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet. 1998;351: 1715-1721.
24. Katayama S, Shionoya H, Ohtake S. A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol Immunol. 1978;22:89-101.
25. Li JJ, Westergaard C, Ghosh P, Colburn NH. Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res. 1997;57:3569-3576.
26. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988;48:4827-4833.
27. Kim HM, Lee YM. Role of TGF-beta 1 on the IgE-dependent anaphylaxis reaction. J Immunol. 1999;162:4960-4965.
28. Sosa Vazquez M, Orea M, Flores G. New concepts about atopic dermatitis. Rev Alerg Mex. 2001;48:15-24.
29. Sampson HA. Mechanisms in adverse reactions to food. The skin. Allergy. 1995;50 Suppl:46-51.
30. Neckermann G, Bavandi A, Meingassner JG. Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981. Br J Dermatol. 2000;142:669-679.
31. Borish L, Joseph BZ. Inflammation and the allergic response. Med Clin North Am. 1992;76:765-787.
32. Mousli MC, Bronner C, Bockaert J, Rouot B, Landry Y. Interaction of substance P, compound 48/80 and mastoparan with α-subunit C-terminal of G protein. Immunol Lett. 1990;25:355-358.
33. Kim HM, Lee YH, Chae HJ, Kim HR, Baek SH, Lim KS, et al. Shini-san inhibits mast cell-dependent immediate-type allergic reactions. Am J Chin Med. 1999;27:377-386.
34. Tasaka K, Mio M, Okamoto M. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann Allergy. 1986;56:464-469.
35. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today. 1990;11:458-464.
36. Plaut M, Pierce JH, Watson CJ, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature. 1989;339:64-67.
37. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med. 1992;176:1381-1386.
38. Jaffe JS, Glaum MC, Raible DG, Post TJ, Dimitry E, Govindarao D, et al. Human lung mast cell IL-5 gene and protein expression: temporal analysis of upregulation following Ig mediated activation. Am J Respir Cell Mol Biol. 1995;13:665-675.
39. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule I. Proc Natl Acad Sci USA. 1991;88:4220-4224.
40. Krishnaswamy G, Martin R, Walker E, Li C, Hossler F, Hall K, et al. Moraxella catarrhalis induces mast cell activation and nuclear factor κB-dependent cytokine synthesis. Front Biosci. 2003;8:40-47.
41. Sumito S, Kawai M, Kasajima Y, Hamamoto T. Increased plasma tumor necrosis factor-alpha concentration in atopic dermatitis. Arch Dis Child. 1992;67:277-279.
42. Groves RW, Allen MH, Ross EL, Barker JNWN, Mac Donald. Tumor necrosis factor alpha is proinflammatory in normal human skin and modulates cutaneous adhesion molecule ecpression. Br J Dermatol. 1995;132:345-352.
43. Kapp A, Textor A, Krutmann J, Moller A. Immunomodulating cytokines in atopic dermatitis and psoriasis: Production of tumor necrosis factor and lymphotoxin by mononuclear cells in vitro. Br J Dermatol. 1990;122:587-592.
44. Osborn L, Hession C, Tizard R, Vassalo C, Luhowsky S, Chi Rosso G, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 1989;59:1203-1211.
45. Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol. 1986;137:1893-1896.
46. Bittlemann D, Casale T. Allergic models and cytokines. Am J Respir Crit Care Med. 1994;150:72-76.
47. De Vries JM, Langeveld-Wildschut EG, van Reijsen FC, Dubios GR, van den Hoek JA, Bihari IC, et al. Adhesion molecule expression on skin endothelia in atopic dermatitis: Effects of TNF-α and IL-4. J Allergy Clin Immunol. 1998;102:461-468.
48. Baggiolini M, Dewald B, Moser B. Interleukin 8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
49. Neuber K, Steinbrucke K, Kowalzik L, Kohler I, Ring J. Cytokine-mediated effects of peripheral blood mononuclear cells from patients in a new coculture system. Br J Dermatol. 1995;133:750-756.
50. Euber K, Hilger RA, Konig W. Interleukin-3, interleukin-8, fMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis. Immunology. 1991;73: 83-87.
51. Van Joost T, Kozel MMA, Tank B, Troost R, Prens EP. Cyclosporin in atopic dermatitis. Modulation in the expression of immunological markers in lesional skin. J Am Acad Dermatol. 1992;27:922-928.
52. Lin TJ, Issekutz TB, Marshall JS. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. J Immunol. 2000;165:211-220.
53. Saito S, Maruyama Y, Kamiyama S, Nakahata N, Ohizumi Y. Ephedrae herba in Mao-Bushi-Saishin-To Inhibits IgE-Mediated Histamine Release and Increases cAMP Content in RBL-2H3 Cells. J Pharmacol Sci. 2004;95:41-46.
54. Moller C, Xiang Z, Nilsson G. Activation of mast cells by immunoglobulin E-receptor cross-linkage, but not through adenosine receptors, induces A1 expression and promotes survival. Clin Exp Allergy. 2003;33:1135-1140.
55. Kim HM, Lee EH, Cho HH, Moon YH. Inhibitory effect of mast cell-mediated immediate type allergic reactions in rats by spirurina. Biochem Pharmacol. 1998;55:1071-1076.
56. Alber G, Miller L, Jelsema C, Varin BN, Metzger H. Structure/function relationships in the mast cell high-affinity receptor for IgE (FcεRI): role of cytoplasmic domains. J Biol Chem. 1991;266:22613-22620.
57. Sarkar A, Sreenivasan Y, Manna SK. alpha-Melanocyte-stimulating hormone induces cell death in mast cells: involvement of NF-kappaB. FEBS Lett. 2003;549:87-93.
58. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene. 1999;18:6853-6866.
59. Barton D, HogenEsch H, Weih F. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol. 2000;30:2323-2332.